➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Cellobiose

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Cellobiose?

Cellobiose is an investigational drug.

There have been 5 clinical trials for Cellobiose. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Federico II University, and [disabled in preview].

There are two US patents protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Cellobiose
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in PediaFederico II UniversityPhase 4
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysGlaxoSmithKlinePhase 2
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.GlaxoSmithKlinePhase 2

See all Cellobiose clinical trials

Clinical Trial Summary for Cellobiose

Top disease conditions for Cellobiose
Top clinical trial sponsors for Cellobiose

See all Cellobiose clinical trials

US Patents for Cellobiose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cellobiose   Get Started Free Infusion methods and products Ocean Spray Cranberries, Inc. (Lakeville-Middleboro, MA)   Get Started Free
Cellobiose   Get Started Free 5-hydroxymethylfurfural production using a multi-fluorinated alcohol compound Klaus-Dieter Vorlop (Braunschweig, DE) Ulf Pruesse (Braunschweig, DE)   Get Started Free
Cellobiose   Get Started Free Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same Novozymes, Inc. (Davis, CA)   Get Started Free
Cellobiose   Get Started Free Desferrithiocin analogs and uses thereof University of Florida Research Foundation, Incorporated (Gainesville, FL)   Get Started Free
Cellobiose   Get Started Free Vasopressin formulations for use in treatment of hypotension Par Pharmaceutical, Inc. (Chestnut Ridge, NY)   Get Started Free
Cellobiose   Get Started Free Method of preparing carboxylic acid functionalized polymers NEKTAR THERAPEUTICS (San Francisco, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cellobiose

Drugname Country Document Number Estimated Expiration Related US Patent
Cellobiose Canada CA2795266 2030-04-06   Get Started Free
Cellobiose Chile CL2012002781 2030-04-06   Get Started Free
Cellobiose World Intellectual Property Organization (WIPO) WO2011127198 2030-04-06   Get Started Free
Cellobiose Brazil BR112017006967 2034-10-09   Get Started Free
Cellobiose Canada CA2964036 2034-10-09   Get Started Free
Cellobiose China CN107108542 2034-10-09   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.